Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss was found in 37.4% of surveyed rural high-school students in Eskisehir, Turkey, affecting their quality of life, especially in general health and mental well-being.

Intralesional triamcinolone acetonide effectively treats alopecia areata, as shown by significant improvements in hair regrowth and dermoscopic indicators.

MRI reveals thinner scalps and smaller hair follicles in people with androgenetic alopecia.

Alopecia Areata greatly affects the quality of life and mental health of Canadian patients and their caregivers.

Early-onset AGA shows different hair and metabolic characteristics compared to normal-onset AGA.

Men with hair loss feel it affects their emotions and life quality, and want more effective treatments.

COVID-19 vaccination does not significantly increase the risk of developing alopecia areata.

Cyclosporin doesn't stop hair loss.

Effective management of children's hair loss involves accurate diagnosis, various treatments, and supportive care.

Hair loss may indicate higher heart risk and metabolic issues.

People with alopecia areata have higher rates of mental health issues, autoimmune diseases, and infections.

JAK inhibitors help hair regrowth in alopecia areata but have a high risk of side effects.

Dermoscopy shows that diffuse alopecia areata progresses through specific hair growth stages.

Contact immunotherapy might help treat various skin conditions, but more research is needed to confirm its safety and effectiveness.

Women with hair loss have more androgen receptors in certain hair follicles.

Alopecia areata severely impacts quality of life, mental health, and work productivity.

New research has found 14 genes linked to the risk of developing alopecia areata, improving understanding and treatment options.

PRP more effective than minoxidil 5% for treating alopecia areata.

Trichobiolight effectively treats hair loss with 82.5% success.

Minoxidil and finasteride can slow hair loss and stimulate regrowth, but won't restore all lost hair or reverse complete baldness.

The meeting focused on understanding, diagnosing, and finding treatments for irreversible hair loss diseases.

Early balding, premature graying, and hair thinning can predict heart disease in young Asian males.

Half of people with Alopecia Areata may see hair regrowth within a year without treatment, but recovery is unpredictable.

Illness perception affects mental health and quality of life in Chinese alopecia patients.

The document concludes that proper diagnosis and FDA-approved treatments for different types of hair loss exist, but treatments for severe cases often fail and future improvements may focus on hair follicle stem cells.

Consider benefits and risks of new alopecia treatments for safety.

The document concludes that oral finasteride and topical minoxidil are effective for genetic hair loss, while other treatments for different types of hair loss show promise but need more research.

Different hair fiber development might explain why hair loss severity varies in patients with a specific genetic mutation, and treatments that thicken hair could help.

We need better research to improve alopecia treatment and patient care.

The document concludes that careful history and physical exams are crucial for accurately diagnosing polycystic ovary syndrome and distinguishing it from other similar conditions.